RudaCure Inc., an 离子通道-targeting 生物风投企业 specializing in novel 药物开发, donated 1 ton of feed to a local stray animal shelter at the end of the year, demonstrating its commitment to community support.
RudaCure announced on the 29th that it delivered 1 ton of cat-specific feed to 'Sansu Angels,' a stray animal shelter located in Namdong-gu, 仁川. This donation was carried out as part of the company's second-half 2025 corporate social responsibility activities.
What makes this donation particularly meaningful is that it was carried out after carefully assessing the shelter's actual needs. While dog food donations are relatively common, cat food is known to be in comparatively short supply. RudaCure reportedly identified these on-site challenges through preliminary research and decided to provide the much-needed cat food support.
A representative from 'Sansu Angels' expressed gratitude, saying, "Dog food donations are always plentiful, but cat food donations are relatively rare, making it difficult to secure enough feed during winter. Since they are a company that also develops animal 制药s, they precisely understood what our shelter needs and prepared food specifically for our cats, which will help us get through the cold winter."
RudaCure is a 生物科技公司 that develops both human and 兽药s. The selection of this particular shelter and the type of donation appear to have been driven by the company's understanding of and interest in animal health.
Members of RudaCure's 疗效 Research Team who participated in the donation event said, "We are delighted to provide practical help to facilities in need in our local community," adding, "We will continue to carry out various CSR activities going forward."
An industry observer noted, "As ESG经营 practices expand among bio-制药公司, more cases like RudaCure's are emerging—going beyond simple donations to providing customized support based on actual field needs. It is particularly noteworthy that a company developing animal 制药s is taking interest in and acting on stray animal welfare, serving as a great example of connecting business with 社会贡献."
RudaCure is a bio风投企业 developing innovative human and 兽药s based on its proprietary drug platform that modulates the TRPV1 (瞫时受体电位香草酸亚型1) 离子通道. The company promotes 可持续经营 through various ESG activities, including community contributions and employee volunteer programs alongside business growth.
Earlier in the first half of the year, RudaCure conducted an employee 献血 campaign and 拾跑 (environmental cleanup) activities, and in the second half expanded its 社会贡献 scope to include stray animal welfare support. The company stated that it plans to continue various 志愿活动 and donations in collaboration with the local community in 2026.
